Sleep drug tested to halt memory loss in At-Risk patients
NCT ID NCT05209035
Summary
This study is testing if a common sleep medication called trazodone can slow down memory loss in people who have both early-stage memory problems (mild cognitive impairment) and obstructive sleep apnea. Researchers believe treating sleep apnea might help protect the brain. Over one year, 134 participants will take either trazodone or a placebo pill to see if it reduces certain blood markers linked to brain decline and improves cognitive scores.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.